Abstract
The expression of P-glycoprotein in primary and recurrent human breast cancer was investigated by means of immunohistochemistry, using a monoclonal antibody (C219) and the streptavidin-biotin-peroxidase method. Twelve patients received no chemotherapeutic treatment. The other 11 patients were treated with chemotherapy, and all developed clinical resistance to it. No or only minimal reactivity was found in specimens coming from the untreated patients (12 cases) or from patients treated with substances not involved in the multidrug resistance phenomenon (four cases). In contrast, three out of seven tumours from patients treated with multidrug resistance related substances showed clear reactivity (positive staining in more than 20% of the tumour cells). In one of these cases, where specimens of the tumour could be studied before and after treatment, an association between the latter and expression of P-glycoprotein was suggested. Finally, this marked expression of P-glycoprotein only took place in tumours treated over a longer space of time (five courses or more of multidrug resistance related chemotherapy).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schneider, J., Bak, M., Efferth, T. et al. P-Glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60, 815–818 (1989). https://doi.org/10.1038/bjc.1989.372
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.372
This article is cited by
-
P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy—a Prospective Clinical Study from a Developing Country
Indian Journal of Surgical Oncology (2018)
-
Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
Cancer Cell International (2006)
-
Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study
World Journal of Surgical Oncology (2005)
-
The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models
British Journal of Cancer (2003)
-
Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy
Breast Cancer Research (2001)